Skip to main content
    W

    Waystar Holding Corp. Common Stock (WAY)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $28.11
    +0.12 (+0.43%)

    Market Cap: $5.39B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Waystar Holding Corp. Common Stock (WAY) P/E Ratio & Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Waystar Holding Corp. Common Stock (WAY) trades at 18.9x trailing earnings and 4.3x sales. Its forward P/E is 14.4x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 31.2% higher over the next year. Its free cash flow yield is 4.9%.

    MultipleValue
    P/E (trailing)18.9x
    Forward P/E14.4x
    Price to sales4.3x
    Price to book1.3x
    EV/EBITDA15.4x
    Price to FCF20.4x
    EV/FCF25.9x
    PEGN/A
    FCF yield4.9%

    As of Nov 17, 2026

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About WAY

    What is WAY's forward P/E ratio?

    Waystar Holding Corp. Common Stock has a forward P/E ratio of 14.4x.

    Is WAY stock overvalued?

    GNG's valuation label for WAY is Undervalued.

    What is WAY's price to sales ratio?

    Waystar Holding Corp. Common Stock has a price to sales ratio of 4.3x.